Maxcyte (MXCT) EBIT Margin Growth (1y) (2021 - 2026)
Maxcyte (MXCT) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 127.31 Bn | 123.83 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 118.93 Bn | 109.71 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 73.35 Bn | 72.82 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 146.00 |
| 10 | Maxcyte | 146.88 Mn | 146.88 Mn | 5.60 Mn | 2,652.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,652.00 |
| Mar 31, 2026 | -1,908.00 |
| Dec 31, 2025 | 44,846.00 |
| Sep 30, 2025 | -3,506.00 |
| Jun 30, 2025 | 7,386.00 |
| Mar 31, 2025 | 10,149.00 |
| Dec 31, 2024 | -18,257.00 |
| Sep 30, 2024 | 16,357.00 |
| Jun 30, 2024 | -9,653.00 |
| Mar 31, 2024 | 4,565.00 |
| Dec 31, 2023 | 5,654.00 |
| Sep 30, 2023 | -26,324.00 |
| Jun 30, 2023 | -5,361.00 |
| Mar 31, 2023 | -22,958.00 |
| Dec 31, 2022 | -2,101.00 |
| Sep 30, 2022 | -4,837.00 |
| Jun 30, 2022 | -2,881.00 |
| Mar 31, 2022 | 11,445.00 |
| Dec 31, 2021 | -1,972.00 |
| Sep 30, 2021 | 3,678.00 |